Rare diseases
Investigational molecules
Locations
Back to Germany212 clinical trials in Homburg, Germany across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of Vosoritide Safety and Effectiveness in Infants and Young Children (0 to 36 months) with Hypochondroplasia
GermanyStudy comparing GSK5764227 and topotecan in adults with relapsed small cell lung cancer
GermanyStudy of alteplase and tenecteplase for intravenous thrombolysis in patients with ischemic stroke who are taking direct oral anticoagulants
GermanyA study of LTP001 in combination with standard treatment for adults with pulmonary arterial hypertension
GermanyStudy of loncastuximab tesirine and epcoritamab combination treatment for patients with relapsed or refractory diffuse large B-cell lymphoma
GermanyStudy of typology-based coaching and education to help patients with early hormone-positive HER2-negative breast cancer manage their treatment with ribociclib
GermanyStudy of deupsilocin besilate (CYB003) in adults with major depressive disorder comparing two doses against placebo
GermanyStudy of patritumab deruxtecan versus drug combination in patients with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer
GermanyLong-term safety and effectiveness study of CYB003 (deupsilocin besilate) with optional additional doses for people with Major Depressive Disorder
GermanyStudy Comparing Golcadomide and Rituximab with Other Treatments for Patients with Relapsed or Refractory Follicular Lymphoma
GermanyStudy on the Effects of Vosoritide for Children with Idiopathic Short Stature
GermanyStudy of Seladelpar Treatment in Patients with Primary Biliary Cholangitis and Compensated Cirrhosis
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on lymphoma and leukemia treatments, including studies evaluating novel therapies for chronic lymphocytic leukemia and various types of B-cell lymphomas.
Multiple trials exploring CAR-T cell therapies and targeted treatment combinations.
Comprehensive studies investigating treatments for various types of breast cancer, particularly focusing on hormone receptor-positive and HER2-positive disease.
Evaluating new combination therapies and targeted treatments for improved patient outcomes.
Studies addressing heart failure prevention and treatment, with innovative approaches to reducing cardiovascular risks.
Testing novel drug combinations to improve cardiovascular outcomes and patient quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
